Background Flat pigmented facial lesions are difficult to diagnose even with dermatoscopy. It is controversial how
Introduction
Facial skin has a particular histologic architecture that differs from skin on other body sites. Pigmented facial lesions are usually examined with the unaided eye and with dermatoscopy. 1, 2 The diagnosis is often challenging because lesions with different biology (melanoma in situ, actinic keratosis, solar lentigo/seborrhoeic keratosis and basal cell carcinoma) may show similar features on dermatoscopy. Facial pigmented lesions often appear on a background of severe sun damage, [3] [4] [5] [6] [7] and collisions 8 are not uncommon. Moreover, biopsies obtained for histopathologic examination may cause scarring and unsatisfactory cosmetic results. The emerging use of non-invasive therapies creates a need for non-invasive diagnostic tools that have a higher specificity than dermatoscopy. Reflectance confocal microscopy (RCM) is an in vivo diagnostic tool that enables horizontal imaging of the upper skin layers providing a near cellular resolution. The method is ideally suited for diagnosis of flat, pigmented lesions on the face [9] [10] [11] [12] [13] with the potential to avoid unnecessary surgical procedures. Facial melanoma in situ (lentigo maligna) is a subtype of melanoma that usually presents as a pigmented macule. Diagnostic features of lentigo maligna (LM) with RCM have been previously described in detail. 9, 12, 14 Guitera et al. 12 developed a diagnostic algorithm for LM, comprising two major diagnostic criteria (non-edged papillae and round large pagetoid cells >20 lm) and four minor criteria (three or more atypical cells at the dermo-epidermal junction in five 0.5 9 0.5 mm 2 fields, atypical cells around the follicle, nucleated cells around the follicle and nucleated cells within the dermal papillae) plus one negative feature (broadened honeycomb pattern). This score achieved a sensitivity of 93% and specificity of 82% for the diagnosis of LM (OR 60.7; 95%; confidence interval: 11.9-309). RCM features of seborrhoeic keratosis, although not specifically on the face, have been evaluated in a study by Ahlgrimm-Siess et al. 15 Likewise, features of basal cell carcinoma 16, 17 and actinic keratosis 18, 19 have been previously described.
A retrospective study 11 confirmed the RCM features of flat pigmented lesions of the face and their correlation with dermatoscopic patterns. RCM features such as atypical cells in the dermo-epidermal junction (DEJ) and epidermis (mainly dendritic cells with adnexal tropism) and a meshwork pattern (corresponding to melanocytic nests) at the dermo-epidermal junction as well as so-called "medusa head-like structures" were predominantly found in lentigo maligna/lentigo maligna melanoma, whereas regular honeycomb and cobblestone pattern and polycyclic contours were predominantly found in benign lesions. Although RCM is regarded as an add-on tool of dermatoscopy, it is controversial how much the additional information obtained by RCM impacts the diagnosis and management of facial lesions in a clinical setting. As many experts of RCM are also experts in dermatoscopy, it is unclear whether the diagnostic accuracy of RCM depends on the correlation with clinical and dermatoscopic information or whether RCM, like histopathology, works as a stand-alone procedure.
Patients & methods
In this prospective study, patients of the outpatient service of the Department of Dermatology, Medical University of Vienna, Austria, were included between November 2013 and May 2015. Eligible participants were individuals over 18 years of age who presented with flat, pigmented lesions of the face that were deemed as suspicious by the dermatologist on duty or a referring dermatologist. Approval of the institutional ethics committee was obtained (EK-No: 1688/2013), and all participants provided their written informed consent. The participants were evaluated in face-to-face (FTF) clinical examination with dermatoscopy by an expert in dermatoscopy who scheduled patients either for biopsy/excision or follow-up visits (3 and 9 months after first visit). Sequential digital dermatoscopy was performed in all lesions scheduled for follow-up. (MoleMax, Derma Medical Systems, Vienna, Austria). In those lesions that were biopsied/excised, histopathologic diagnosis and images were obtained. For the purpose of documentation, we acquired clinical and dermatoscopic images of all lesions. We performed RCM in all lesions. The RCM images were then sent to one of seven expert confocal readers (randomly selected) who were blinded to the clinical and dermatoscopic appearance of the lesion, the clinical diagnosis and the clinical data of the patients. The details of the study design are shown in Fig. 1 .
The expert dermatoscopist and the confocal readers provided one main diagnosis and up to two differential diagnoses. They also rated the suspected level of malignancy on a 5-point VAS scale (0 = definitive benign, 5 = definitive malignant; actinic keratosis was considered malignant) and the suspected probability of diagnosis of a lentigo maligna on a 5-point VAS scale. (0 = LM ruled out, 5 = LM without doubt). The confocal readers additionally rated image quality on a 5-point VAS scale (0 = best possible rating) (Figs. 2-5).
For those lesions that were excised, histopathologic diagnosis served as reference standard. Lesions that were not excised were regarded as definitely benign if there was no major change (as compared to baseline digital dermatoscopic and clinical images) in the 9-month follow-up period. When lesions were excised due to change or because they were diagnosed as malignant by confocal readers, histopathologic diagnosis served as reference standard.
Image acquisition
In all lesions, RCM imaging with a commercially available confocal microscope (Vivascope 1500 â , MAVIG Gmbh, Munich, Germany) was performed following a standardized imaging protocol. At least one mosaic of 5-7 mm 2 at the level of the epidermis, the dermo-epidermal junction (DEJ) and papillary dermis, respectively, was obtained (approximate depth from the skin surface: 20 lm, 50 lm and 70 lm).
Results
We invited 67 patients with 73 lesions to participate in the study. In three patients, it was impossible to obtain RCM images due to anatomic site (eyebrow, infraorbital region and nose tip, respectively). Finally, we included 70 lesions of 65 patients (34 male, 31 female; mean age 68 years; median age 69 years; age range 36-93 years). Of the 70 lesions, 35 (50.0%) were on the cheek, 12 (17.1%) were on the forehead, 10 (14.3%) were on the nose, six (8.6%) were on the temple, two (2.9%) were on the chin, ear and preauricular area, respectively, and one (1.4%) was on the upper lip. Considering only the main diagnosis of the FTF dermatoscopist, a sensitivity of 73.7% (95% CI 48.80% to 90.85%) and a specificity of 98.1% (95% CI 89.74% to 99.95%) were achieved. Considering the main and first differential diagnosis (thus taking into account lesions that were suspected as benign but excised or biopsied because malignancy could not be ruled out), the sensitivity of dermatoscopy was 85.0% (95% CI 62.11% to 96.79%) and the specificity was 84.0% (95% CI 70.89% to 92.83%). The sensitivity of dermatoscopy plus digital dermatoscopic monitoring was 95.0% (95% CI 75.13% to 99.87%), and the specificity was 84.0% (95% CI 70.89% to 92.83%). For RCM, the sensitivity was 95.0% (95% CI 75.13% to 99.87%) and the specificity was 82.0% (95% CI 68.56% to 91.42%), which remained unchanged when differential diagnoses were considered.
A combined approach where every lesion was biopsied that was deemed suspicious either in dermatoscopy or in RCM (as it was performed in this study setting) achieved a sensitivity of 100.0% (95% CI 83.16% to 100.00%) and a specificity of 74.0% (95% CI 59.66% to 85.37%) in this study population.
In our study set, there were 15 histopathologically confirmed lentigo maligna (LM) and one invasive melanoma. Of these 16 melanomas, nine were diagnosed correctly both by the FTF dermatologist and confocal reader. Two LM that were assigned to biopsy by the FTF dermatoscopist were diagnosed as solar lentigo by RCM, but the differential diagnoses included LM (see also Tables 1 and 2 ).
Regarding management decision at the baseline visit, management procedure (excision/biopsy vs follow-up) recommended by FTF dermatologist and confocal reader was the same in 57 lesions, whereas it differed in 13 lesions. Four lesions that were biopsied or excised at baseline by the FTF dermatologist were identified correctly as benign by RCM. Three lesions that were identified correctly as LM in RCM were assigned to follow-up by the FTF dermatologist. Of those, two lesions showed change in 3-month follow-up visit, and one did not. All three lesions were excised at 3-month follow-up visit (two due to change plus suspicion of LM in RCM plus one due to suspicion of LM in RCM). One AK in histopathology was correctly identified by FTF dermatologist but diagnosed as LPLK by confocal reader and thus would not have been biopsied/excised, leading to one false-negative result by RCM, although no LM was missed. Two lesions that were diagnosed as solar lentigo by histopathology and FTF diagnosis were suspected as LM in RCM (see Fig. 1 ).
Discussion
Facial melanoma in situ (lentigo maligna) is often diagnosed when it reached a considerable size spreading to areas where cosmetic considerations play an important role and functionality may be impaired by surgery. Furthermore, there is a risk of progression to invasive melanoma if left untreated. 20 Facial skin *Three excised due to patient wish, two excised due to suspicion of malignancy in RCM †All three suspicions of malignancy in RCM, of those two showed change in 3-month FU. FTF, face to face; LM, lentigo maligna; BCC, basal cell carcinoma; AK, actinic keratosis; FUnc, no change in follow-up.
tends to be thinner than skin on other body areas, making it ideally suited for RCM, which provides a resolution comparable to conventional histology but has a limited imaging depth to approximately 150 lm from skin surface. Therefore, this investigation exclusively focuses on flat facial lesions In the prospective design of the study, we aimed to test the additional value of RCM in a 'real-life' setting including patients referred by either the dermatologist on duty or referring dermatologists in private practice. Therefore, we had a high number of benign lesions in our test set. Among our case series were 15 histopathologically confirmed LM and one invasive melanoma. Of those, 14 lesions were identified by dermatoscopy or dermatoscopy follow-up which gave a sensitivity of 95.0%, whereas one lesion could be identified only by RCM. Five lesions showed features of actinic keratosis in RCM, but none of these five showed clinical signs of AK or, if biopsied, were histopathologically diagnosed as AK. This might be due to the fact that the facial skin is more exposed to UV light and therefore shows more subclinical signs of actinic damage compared to other body sites.
The results underline that RCM is a valid non-invasive method to detect LM. The main indication includes suspicious lesions selected by an experienced dermatologist/dermatoscopist. Even though the time needed for RCM examination of single lesions might be reduced using a handheld tool, it is still a timeconsuming procedure. It might not be suitable for routine diagnosis of numerous lesions, but should be applied to lesions of special interest following dermatoscopy. Digital dermatoscopic monitoring is a valid alternative if RCM is not available for flat facial lesions. A study by Altamura et al. 21 showed that in seventy-five per cent of lentigo maligna melanomas, change can be detected by short-term sequential digital dermatoscopic imaging within three months. However, benign lesions, especially lichen planus-like keratosis, may change too. Facial lentigo maligna usually grows slowly, 22 and delay of diagnosis carries a lower risk than in melanocytic lesions on other body sites. Besides diagnosis, it has been shown by others that RCM is also valid for the presurgical mapping/guidance of biopsy side selection of larger lesions and for the monitoring of treatment response of nonsurgical treatment. This, however, was not the focus of this investigation. 23 We showed that most flat pigmented facial lesions can be managed by clinical examination and dermatoscopy (plus digital dermatoscopic follow-up) alone but we also confirm that RCM is a useful adjunct in selected lesions.
The specificity of confocal microscopy slightly decreases if it is not correlated with clinical and dermatoscopic information. However, in clinical setting, it is routinely used as an adjunct to clinical and dermatoscopic examination and it has been demonstrated as an useful tool to increase diagnostic accuracy in prospective studies. 24, 25 Furthermore, the current study has an impact on clinical procedures. Optimally, the clinician who examines suspicious flat pigmented lesions should be an expert in dermatoscopy and RCM. The isolated examination of RCM images bears the risk of inaccurate diagnosis. This is quite different from histopathology where in many lesions, the histopathologist does not have clinical information or images. The results of our study indicate that for RCM, a clinic-pathologic correlation is important and should ideally be made at the patient visit. The need of full contact between the RCM device and the skin is challenging on the face due to the convex and concave areas and led to exclusion of some lesions for this study which has been performed with a conventional confocal microscope rather than with a smaller handheld device that is commercially available (Vivascope 3000). This handheld device has been shown to be useful on curvy anatomical sites, (especially as these sites are often the ones where operation might render more difficulty). [26] [27] [28] [29] The possibility of obtaining a larger area of view with the handheld confocal microscope may facilitate its usability. 30 Like any clinical tool, training is required for effective use and diagnostic accuracy of both methods is dependent on evaluator experience. We think that the preference of use of RCM or dermatoscopy should depend on training and local resources.
The results of the study presented herein add to the larger scale validation that is needed for more widespread adoption of this technology. The value of RCM in diagnosis of flat pigmented lesions
In conclusion, RCM is a valid diagnostic method for flat pigmented lesions on the face, complementary to dermatoscopic evaluation. RCM diagnosis alone, without clinical and dermatoscopic information, might lead to overdiagnosis of actinic keratosis and even lentigo maligna, however.
